Health Economics, Policy and Law
2006 - 2025
From Cambridge University Press Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK. Bibliographic data for series maintained by Kirk Stebbing (). Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.
Volume 13, issue 3-4, 2018
- Space, place and (waiting) time: reflections on health policy and politics pp. 226-250

- Sally Sheard
- Can history improve big bang health reform? Commentary pp. 251-262

- Gregory P. Marchildon
- Bitter pills: the impact of medicare on mental health pp. 263-279

- Erika Dyck
- Medicare and the care of First Nations, Métis and Inuit pp. 280-298

- Josée G. Lavoie
- Pharmaceutical policy reform in Canada: lessons from history pp. 299-322

- Katherine Boothe
- Expanding Canadian Medicare to include a national pharmaceutical benefit while controlling expenditures: possible lessons from Israel pp. 323-343

- Bruce Rosen
- Expanding the breadth of Medicare: learning from Australia pp. 344-368

- Stephen Duckett
- Why policy needs history (and historians) pp. 369-381

- Virginia Berridge
- The impact of slow economic growth on health sector reform: a cross-national perspective pp. 382-405

- Richard B. Saltman
- Rising inequality and the implications for the future of private insurance in Canada pp. 406-432

- Mark Stabile and Maripier Isabelle
- A successful Charter challenge to medicare? Policy options for Canadian provincial governments pp. 433-449

- Colleen M. Flood and Bryan Thomas
- Doctors as Stewards of medicare, or not: CAMSI, MRG, CDM, DRHC and the thin alphabet soup of physician support pp. 450-474

- Jacalyn Duffin
- Nurses as change agents for a better future in health care: the politics of drift and dilution pp. 475-491

- Anne M. Rafferty
- Competition in health care: lessons from the English experience pp. 492-508

- Carol Propper
Volume 13, issue 2, 2018
- Creating a ‘hostile environment for migrants’: the British government’s use of health service data to restrict immigration is a very bad idea pp. 107-117

- Lucinda Hiam, Sarah Steele and Martin McKee
- The Norwegian National Council for Priority Setting in Health Care: decisions and justifications 1 pp. 118-136

- Gry Wester and Berit Bringedal
- Who’s afraid of institutionalizing health technology assessment (HTA)?: Interests and policy positions on HTA in the Czech Republic pp. 137-161

- Olga Löblová
- Involving citizens in disinvestment decisions: what do health professionals think? Findings from a multi-method study in the English NHS pp. 162-188

- Tom Daniels, Iestyn Williams, Stirling Bryan, Craig Mitton and Suzanne Robinson
- What should health insurance cover? A comparison of Israeli and US approaches to benefit design under national health reform pp. 189-208

- Rachel Nissanholtz Gannot, David P. Chinitz and Sara Rosenbaum
- ‘Fair innings’ in the face of ageing and demographic change pp. 209-217

- Nisha C. Hazra, Martin C. Gulliford and Caroline Rudisill
Volume 13, issue 1, 2018
- The state of American health care: November 2016 to November 2020, a look forward pp. 1-9

- Theodore Marmor and Michael K. Gusmano
- The efficiency of the local health systems: investigating the roles of health administrations and health care providers pp. 10-32

- Laura Anselmi, Mylène Lagarde and Kara Hanson
- Adopting new medical technologies in Russian hospitals: what causes inefficiency? (qualitative study) pp. 33-49

- Sergey Shishkin and Liudmila Zasimova
- Outsourcing day surgery to private for-profit hospitals: the price effects of competitive tendering pp. 50-67

- Terje P. Hagen, Geir Hiller Holom and Kebebew N. Amayu
- The incidence of health financing in South Africa: findings from a recent data set pp. 68-91

- John Ataguba and Di McIntyre
- Legal advocacy as a tool to advance Roma Health pp. 92-105

- Tamar Ezer, Alphia Abdikeeva and Martin McKee
Volume 12, issue 4, 2017
- Health equality, social justice and the poverty of autonomy pp. 411-433

- Christopher Newdick
- Innovation, informed consent, health research and the Supreme Court: Montgomery v Lanarkshire – a brave new world? pp. 435-452

- Jean V. Mchale
- Healthcare innovation and patent law’s ‘pharmaceutical privilege’: is there a pharmaceutical privilege? And if so, should we remove it? pp. 453-470

- Graham Dutfield
- Regulatory theory: commercially sustainable markets rely upon satisfying the public interest in obtaining credible goods 1 pp. 471-493

- Amanda Warren-Jones
- Legal and organisational innovation in the Italian pharmacy system: commercial vs public interest pp. 495-513

- Alceste Santuari
Volume 12, issue 3, 2017
- A place in the sun? Healthcare rights of retired UK citizens in Spain post-Brexit pp. 297-307

- Joaquin Cayon-De Las Cuevas and Tamara Hervey
- Democratic transitions, health institutions, and financial protection in the emerging economies: insights from Asia pp. 309-323

- Eduardo J. Gómez
- Contested evidence: a Dutch reimbursement decision taken to court pp. 325-344

- Floortje Moes, Eddy Houwaart, Diana Delnoij and Klasien Horstman
- Health plan choice in the Netherlands: restrictive health plans preferred by young and healthy individuals pp. 345-362

- Romy E. Bes, Emile C. Curfs, Peter P. Groenewegen and Judith D. de Jong
- The determinants of defensive medicine practices in Belgium pp. 363-386

- Tom Vandersteegen, Wim Marneffe, Irina Cleemput, Dominique Vandijck and Lode Vereeck
- Identifying health system value dimensions: more than health gain? pp. 387-400

- Joan Costa-Font, Azusa Sato and Joan Rovira Forns
- Contested evidence: a Dutch reimbursement decision taken to court – CORRIGENDUM pp. 401-401

- Floortje Moes, Eddy Houwaart, Diana Delnoij and Klasien Horstman
Volume 12, issue 2, 2017
- What level of domestic government health expenditure should we aspire to for universal health coverage? pp. 125-137

- Di Mcintyre, Filip Meheus and John-Arne Røttingen
- Raising more domestic money for health: prospects for low- and middle-income countries pp. 139-157

- Riku Elovainio and David B. Evans
- Fiscal space for domestic funding of health and other social services pp. 159-177

- Filip Meheus and Di McIntyre
- Framing the tax and health nexus: a neglected aspect of public health concern pp. 179-194

- David Mccoy, Simukai Chigudu and Taavi Tillmann
- Global public goods for health: weaknesses and opportunities in the global health system pp. 195-205

- Suerie Moon, John-Arne Røttingen and Julio Frenk
- Development assistance for health: critiques, proposals and prospects for change pp. 207-221

- Suerie Moon and Oluwatosin Omole
- Development assistance for health: what criteria do multi- and bilateral funders use? pp. 223-244

- Trygve Ottersen, Aparna Kamath, Suerie Moon, Lene Martinsen and John-Arne Røttingen
- Distributing development assistance for health: simulating the implications of 11 criteria pp. 245-263

- Trygve Ottersen, Suerie Moon and John-Arne Røttingen
- The challenge of middle-income countries to development assistance for health: recipients, funders, both or neither? pp. 265-284

- Trygve Ottersen, Suerie Moon and John-Arne Røttingen
- Towards a coherent global framework for health financing: recommendations and recent developments pp. 285-296

- Trygve Ottersen, Riku Elovainio, David B. Evans, David McCoy, Di Mcintyre, Filip Meheus, Suerie Moon, Gorik Ooms and John-Arne Røttingen
Volume 12, issue 1, 2017
- The regulation of competition in the National Health Service (NHS): what difference has the Health and Social Care Act 2012 made? pp. 1-19

- Marie Sanderson, Pauline Allen and Dorota Osipovic
- Complementary logics of target-setting: hierarchist and experimentalist governance in the Scottish National Health Service pp. 21-41

- Laura Schang and Alec Morton
- The European Union Joint Procurement Agreement for cross-border health threats: what is the potential for this new mechanism of health system collaboration? pp. 43-59

- Natasha Azzopardi-Muscat, Peter Schroder-Bäck and Helmut Brand
- The double-edged sword of corporatisation in the hospital sector: evidence from Indonesia pp. 61-80

- Asri Maharani and Gindo Tampubolon
- The United States confronts Ebola: suasion, executive action and fragmentation pp. 81-104

- Scott L. Greer and Phillip M. Singer
| |